AbbVie Inc (ABBV)
Number of days of payables
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Payables turnover | — | — | — | — | — | |
Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for AbbVie Inc's number of days of payables from December 31, 2020, to December 31, 2024 indicates that the number of days of payables is not available or not reported for these years. Without specific values for the number of days of payables, it is difficult to evaluate the efficiency of AbbVie Inc's management of its payables during these periods. Further information or data is required to conduct a comprehensive analysis of AbbVie Inc's payables turnover and working capital management.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
AbbVie Inc
ABBV
—
Abbott Laboratories
ABT
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
43.80
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.38
Catalyst Pharmaceuticals Inc
CPRX
—
Collegium Pharmaceutical Inc
COLL
—